Carmell Therapeutics Corporation (CTCX) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
0125K250K375K500K625K750K875K1MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Operating Expenses

Research And Development ExpensesSelling And Marketing ExpensesGeneral And Administrative ExpensesOther Expenses
0375K750K1M2M2M2M3M3MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

EBITDA

EBITDA
-4M-3M-3M-2M-2M-1M-1000K-500K1Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

EPS

Revenue Variation (%)

Revenue Variation
-204829851K2K2K3K3K4KQ3 2024Q4 2024Q1 2025Q2 2025

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
02505007501K1K2K2K2KQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Revenue YoY Variation (%)

Revenue YoY Variation
-2004501K2K2K3K4K4K5KQ3 2024Q4 2024Q2 2025

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
03757501K2K2K2K3K3KQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Price-to-Earning Ratio

P/E Ratio
-90-79-67-56-44-33-22-101Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)
01K2K3K4K6K7K8K9KQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Per Share Metrics

Operating IncomeTotal Other Income Expenses NetNet Income
02505007501K1K2K2K2KQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
000001111Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025
💰 Cash Flow Statement

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
048111519222630Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
011223445Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Cash Flow to Debt Ratio

Cash At End Of Period
0375K750K1M2M2M2M3M3MQ2 2024Q3 2024Q4 2024
🏦 Balance Sheet
📈 Key Metrics